ros1 gene rearrangement
Showing 1 - 3 of 3
Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)
Recruiting
- Non-squamous Non-small-cell Lung Cancer
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Nsclc, EGFR Activating Mutation, EGF-R Positive NSCLC Trial in Hong Kong (Pembrolizumab, Lenvatinib, Pemetrexed)
Recruiting
- Nsclc
- +5 more
- Pembrolizumab
- +3 more
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 25, 2021
Lung Cancer, ROS1 Gene Rearrangement Trial in Shanghai (X-396 Capsule)
Unknown status
- Lung Cancer
- ROS1 Gene Rearrangement
- X-396 Capsule
-
Shanghai, Shanghai, ChinaChest hospital affiliated to Shanghai jiao tong university
Jan 6, 2020